Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Pan-Cancer Analysis of Predictive Methylation Signatures of Response to Cancer Immunotherapy

9 Dec 2021

Abstract excerpt

Recently, tumor immunotherapy based on immune checkpoint inhibitors (ICI) has been introduced and widely adopted for various tumor types. Nevertheless, tumor immunotherapy has a few drawbacks, including significant uncertainty of outcome, the possibility of severe immune-related adverse events for patients receiving such treatments, and the lack of effective biomarkers to determine the ICI treatments'...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Cancer Immunotherapy and Biomarkers
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34956232
DOI: 10.3389/fimmu.2021.796647

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Pan-Cancer Analysis of Predictive Methylation Signatures of Response to Cancer ImmunotherapyPMID 34956232Read ↗

Epigenetic Perspective of Immunotherapy for CancersSemantic proximity Read ↗

Epigenome-Driven Strategies for Personalized Cancer ImmunotherapySemantic proximity Read ↗

A pan-cancer analysis revealing the role of TIGIT in tumor microenvironment.Semantic proximity Read ↗

Genetic and Epigenetic Biomarkers of Immune Checkpoint Blockade ResponseSemantic proximity Read ↗

CAMOIP: A Web Server for Comprehensive Analysis on Multi-Omics of Immunotherapy in Pan-cancerSemantic proximity Read ↗

PTPRD/PTPRT mutation as a predictive biomarker of immune checkpoint inhibitors across multiple cancer types.Semantic proximity Read ↗

CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancer.Semantic proximity Read ↗

FDA-Approved and Emerging Next Generation Predictive Biomarkers for Immune Checkpoint Inhibitors in Cancer PatientsSemantic proximity Read ↗

IP-score correlated to endogenous tumour antigen peptide processing: A candidate clinical response score algorithm of immune checkpoint inhibitors therapy in multiple cohortsSemantic proximity Read ↗

Pan-cancer methylation analysis reveals an inverse correlation of tumor immunogenicity with methylation aberrancy.Semantic proximity Read ↗

Pan-cancer analysis of DNMT3A as a robust prognostic biomarker to predict the immunotherapy responseSemantic proximity Read ↗

Epigenetic modulation in cancer immunotherapySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.